A. Alwazzan, “Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction”, World J Oncol, vol. 17, no. 5, pp. 676–682, Jan. 2026, doi: 10.14740/wjon2800.